Pharmacotherapeutic options for pancreatic ductal adenocarcinoma.

Muhammad SardarAlejandro Recio-BoilesKabir ModyChristian KarimeSreenivasa R ChandanaDaruka MahadevanJason StarrJeremy JonesMitesh BoradHani Babiker

Published in: Expert opinion on pharmacotherapy (2022)

Thorough understanding of molecular pathogenesis in PDAC has opened various therapeutic avenues. We remain optimistic that future treatment modalities such as targeted therapies, cellular therapies and immunotherapy will further improve survival in PDAC.

Keyphrases

current status
combination therapy
single molecule